Reagents and instruments for immunology, cell biology and molecular biology.

Biorbyt

Biorbyt is a UK-based supplier specializing in life science reagents. They offer a wide range of products, including antibodies, ELISA kits, small molecules, and proteins. Researchers can choose from thousands of research antibodies and reagents for various applications. Biorbyt collaborates with top scientists and scholars to develop high-quality products, covering areas such as immunology, cell biology, molecular biology, and proteinomics. Their comprehensive offerings include immune assays, protein mass spectrometry, cell culture, custom antibody services, animal model establishment, and biochemical reagents.

Biorbyt provides valuable reagents and services for biological research. With a wide selection of antibodies, assay kits, small molecules, and proteins, Biorbyt supports scientists in their experiments. They have established stable partnerships with renowned universities, research institutes, pharmaceutical companies, biotech firms, and hospitals worldwide. Biorbyt’s commitment to high-quality products and professional technical services spans immunology, cell biology, molecular biology, proteinomics, and more.

Learn more :



Antibodies - Chicken Ig Why ?	Cancer Pathways Apoptosis Signaling	Fix & Perm Cell Fixation and Permeabilization


Immunology Pathways	Products for advancing discoveries	Working in larger model animal species

Watch the videos:




Recombinant Antibodies				Cancer Biomarkers

Website : https://www.biorbyt.com/

COVID-19

A new coronavirus (Covid-19 / 2019-nCoV) close to the Severe Acute Respiratory Syndrome (SARS) virus and the Middle East Respiratory Syndrome Virus (MERS) was discovered in early January in the city of Wuhan, China.

The symptoms of this new coronavirus infection are similar to those of seasonal flu, SARS or MERS. Transmission and incubation time also appear to be similar to other coronaviruses. Coronavirus Covid-19 (2019-nCoV) appears to be slightly more contagious than seasonal influenza virus and its infection is slightly more severefor susceptible individuals.

For much of their known history, the coronaviruses were regarded as relatively benign pathogens with little potential to cause human harm. However, the emergence of SARS and MERS in recent decades has brought coronaviruses into the global spotlight and they are now included on the World Health Organization's List of Blueprint Priority Diseases. To support ongoing research and development, we offers a complete range of products for this family of viruses.

Antibodies

Antigens

Molecular tests

RNA extraction

Serological tests

Therapeutic candidates